increased from THB 82.00 million to THB 133.61 million or increased THB 51.61 million or 62.94% because film production and films rights distribution generated more revenue than last year. Cost and expense of
Ministry of Public Health’s Center for Disease Control and the Order of the Centre for COVID-19 Situation Administration (CCSA) so the Company could not release our films in cinema. Cost and expense of
14.61 million or increased THB 56.88 million or 134.57% because film production and distribution films’ right generated more revenue. Moreover, cost and expense of the Company was managed more effectively
cost and expense saving program which INGRS has fully implemented. Regarding profit attributable to equity holders of INGRS, for the 6-months and 3-months periods ended 31 July 2017, INGRS registered the
and Expense Structure Cost of Hospital Operations(excl. depreciation) 479.7 446.8 32.9 7.4% 241.8 228.0 13.8 6.1% Depreciation Cost 35.4 25.7 9.7 37.6% 17.9 12.9 5.0 38.5% Cost of Services 45.4 37.7 7.7
3,419 771 23% Cost of Sales and Service -3,537 -2,766 771 28% -3,170 -2,618 552 21% Gross Profit 1,194 947 247 26% 1,020 801 219 27% Other Income 65 26 39 153% 92 53 39 72% Selling Expense -328 -297 31 11
the year 2019 increased by 144% compared to the same period of 2018. The main reasons were Cost and selling expense increased 7% due to cost of employee benefit expense and cost of event increased
main reasons were Cost and selling expense increased 7% due to cost of employee benefit expense and cost of event increased. Administrative expense decreased 42% due to the Company had restructuring
construction of Lumphun Plant were included in administrative expense, while cost of distribution decreased from sales volume. In the third quarter of 2018, the company did not have financial cost, as the
) Total revenue 1,819,624 1,272,735 546,889 42.97 Total Cost & Expense 1,685,730 1,222,945 462,785 37.84 Selling & Admin. Expense 303,598 257,018 46,580 18.12 Finance cost 77,519 72,753 4,766 6.55 Net